Inserm (Institut Nat De La Sante Et De La Rech Medicale)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inserm (Institut Nat De La Sante Et De La Rech Medicale)filedCriticalInserm (Institut Nat De La Sante Et De La Rech Medicale)
Publication of AR104204A1publicationCriticalpatent/AR104204A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Tratamiento y prevención de trastornos del movimiento con la administración de uno o más precursores de propionil-CoA. Reivindicación 6: El método de la reivindicación 5, donde el precursor de propionil-CoA es triheptanoína.Treatment and prevention of movement disorders with the administration of one or more propionyl-CoA precursors. Claim 6: The method of claim 5, wherein the propionyl-CoA precursor is triheptanoin.
ARP160100943A2015-04-072016-04-07
COMPOSITIONS AND METHODS FOR THE TREATMENT OF MOVEMENT DISORDERS
AR104204A1
(en)
Compounds derived from 2-8-5-chloropyrimidin-2-ylamino-6,7,8,9-tetrahydro-5h-pyrido3,2-bindol-5-ylacetic acid, modulators of the prostaglandin d2 receptor pharmaceutical composition and its use for the treatment of diseases allergic immune disorders.
Antihyperalgesic, antiallodynic and anti-inflammatory pharmacological combination, pharmaceutical compositions containing same and use thereof for treating neuropatic pain.